These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34260655)

  • 1. Neuroprotective action of Cortexin, Cerebrolysin and Actovegin in acute or chronic brain ischemia in rats.
    Kurkin DV; Bakulin DA; Morkovin EI; Kalatanova AV; Makarenko IE; Dorotenko AR; Kovalev NS; Dubrovina MA; Verkholyak DV; Abrosimova EE; Smirnov AV; Shmidt MV; Tyurenkov IN
    PLoS One; 2021; 16(7):e0254493. PubMed ID: 34260655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of protective effects of Cortexin, Cerebrolysin and Actovegin on memory impairment, cerebral circulation and morphological changes in the hippocampus of rats with chronic brain ischemia].
    Tyurenkov IN; Kurkin DV; Kalatanova AV; Dorotenko AR; Bakulin DA; Morkovin EI; Verholyak DV; Gorbunova YV; Atapina NV; Smirnov AV; Schmidt MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(8):83-89. PubMed ID: 32929929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antioxidant effect of cortexin, cerebrolysin and actovegin in rats with chronic cerebrovascular insufficiency].
    Kurkin DV; Morkovin EI; Kalatanova AV; Bakulin DA; Verholyak DV; Kovalev NS; Dubrovina MA; Tyurenkov IN; Petrov VI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(7):84-89. PubMed ID: 34460162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective, double blinded, comparative assessment of the pharmacological activity of Cerebrolysin and distinct peptide preparations for the treatment of embolic stroke.
    Zhang L; Chopp M; Wang C; Zhang Y; Lu M; Zhang T; Zhang ZG
    J Neurol Sci; 2019 Mar; 398():22-26. PubMed ID: 30665068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of behavioral effects of cortexin and cerebrolysine upon intraventricular and intraperitoneal administration in rats].
    Shabanov PD; Lebedev AA; Pavlenko VP; Ganapol'skiĭ VP
    Eksp Klin Farmakol; 2007; 70(3):13-9. PubMed ID: 17650626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with Actovegin improves spatial learning and memory in rats following transient forebrain ischaemia.
    Meilin S; Machicao F; Elmlinger M
    J Cell Mol Med; 2014 Aug; 18(8):1623-30. PubMed ID: 24797227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphofunctional effects of moderate forebrain ischemia combined with short-term hypoxia in rats--protective effects of Cerebrolysin.
    Schwab M; Schaller R; Bauer R; Zwiener U
    Exp Toxicol Pathol; 1997 Feb; 49(1-2):29-37. PubMed ID: 9085071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological effects and brain protection by hypothermia and cerebrolysin after moderate forebrain ischemia in rats.
    Schwab M; Bauer R; Zwiener U
    Exp Toxicol Pathol; 1997 Feb; 49(1-2):105-16. PubMed ID: 9085084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrolysin dose-dependently improves neurological outcome in rats after acute stroke: A prospective, randomized, blinded, and placebo-controlled study.
    Zhang L; Chopp M; Lu M; Zhang T; Winter S; Doppler E; Meier D; Chao L; Eapen A; Pabla P; Gang Zhang Z
    Int J Stroke; 2016 Apr; 11(3):347-55. PubMed ID: 26763925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of therapeutic window of Cerebrolysin in embolic stroke: A prospective, randomized, blinded, and placebo-controlled study.
    Zhang L; Chopp M; Lu M; Zhang T; Li C; Winter S; Brandstaetter H; Doppler E; Meier D; Pabla P; Zhang ZG
    Int J Stroke; 2017 Aug; 12(6):628-635. PubMed ID: 28382851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative analysis of efficacy of certain neuroprotectors in ischemic stroke].
    Skorokhodov AP; Dudina AA; Kolesnikova EA; Koron AE; Kobantsev IuA; Sedova AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 17():52-6. PubMed ID: 18193579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in functional recovery with administration of Cerebrolysin after experimental closed head injury.
    Zhang Y; Chopp M; Meng Y; Zhang ZG; Doppler E; Mahmood A; Xiong Y
    J Neurosurg; 2013 Jun; 118(6):1343-55. PubMed ID: 23581594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superior neuroprotective effects of cerebrolysin in heat stroke following chronic intoxication of Cu or Ag engineered nanoparticles. A comparative study with other neuroprotective agents using biochemical and morphological approaches in the rat.
    Sharma HS; Muresanu DF; Patnaik R; Stan AD; Vacaras V; Perju-Dumbrav L; Alexandru B; Buzoianu A; Opincariu I; Menon PK; Sharma A
    J Nanosci Nanotechnol; 2011 Sep; 11(9):7549-69. PubMed ID: 22097459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of the nootropic agent cerebrolysin in cerebral ischemia in rats with varying behavioral reactions in the open field test].
    Gannushkina IV; Antelava AL; Baranchikova MV
    Patol Fiziol Eksp Ter; 1998; (2):3-8. PubMed ID: 9633187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrolysin improves cognitive performance in rats after mild traumatic brain injury.
    Zhang Y; Chopp M; Meng Y; Zhang ZG; Doppler E; Winter S; Schallert T; Mahmood A; Xiong Y
    J Neurosurg; 2015 Apr; 122(4):843-55. PubMed ID: 25614944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disorders.
    Masliah E; Díez-Tejedor E
    Drugs Today (Barc); 2012 Apr; 48 Suppl A():3-24. PubMed ID: 22514792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of behavioral effects of cortexin and cerebrolysin injected into brain ventricles.
    Shabanov PD; Lebedev AA; Stetsenko VP; Lavrov NV; Markov SV; Vojeikov IV
    Bull Exp Biol Med; 2007 Apr; 143(4):437-41. PubMed ID: 18214294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrolysin reduces blood-cerebrospinal fluid barrier permeability change, brain pathology, and functional deficits following traumatic brain injury in the rat.
    Sharma HS; Zimmermann-Meinzingen S; Johanson CE
    Ann N Y Acad Sci; 2010 Jun; 1199():125-37. PubMed ID: 20633118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative studies of neurotrophic drugs based on brain hydrolysates].
    Gromova OA; Torshin IY; Stakhovskaia LV; Maiorova LA; Ostrenko KS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(10):134-140. PubMed ID: 31793555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.